药明康德再度减持药明合联:套现22亿港元背后的战略考量

观察者网
03 Apr

【文/王力 编辑/周远方】4月2日,药明康德(603259.SH、02359.HK)宣布通过大宗交易减持药明合联(02268.HK)5080万股股票,约占药明合联总股本的4.23%,成交金额约为21.78亿港元。这是自2024年11月以来,药明康德第三次减持药明合联,累计减持金额已达到46亿港元。此次减持正值药明合联股价创下历史新高之际。(药明合联股价走势)近年来,全球医药外包行业竞争加剧,药明...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10